Advanced-Stage Follicular Lymphoma in the Rituximab Era: When Should Patients Receive Anthracycline-Based Chemotherapy?

By Pettengell Ruth  

Drugs, Vol. 69, Iss. 13, 2009-09 ,pp. : 1727-1737

Adis International

Access to resources Recommend Favorite

An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK

By Ray Joshua A.   Carr Emma   Lewis Gavin   Marcus Robert  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 346-357

Blackwell Publishing

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of the Addition of Rituximab to CHOP in Young Patients with Good-Prognosis Diffuse Large-B-Cell Lymphoma

By Ferrara Felicetto  

Clinical Drug Investigation, Vol. 28, Iss. 1, 2008-01 ,pp. : 55-65

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation

By Deconinck Eric  

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite

HMG versus rFSH for ovulation induction in developing countries: a cost–effectiveness analysis based on the results of a recent meta-analysis

By Al-Inany Hesham G   Abou-Setta Ahmed M   Aboulghar Mohamed A   Mansour Ragaa T   Serour Gamal I  

Reproductive BioMedicine Online, Vol. 12, Iss. 2, 2006-02 ,pp. : 163-169

Reproductive Healthcare Ltd

Access to resources Recommend Favorite